Navigation Links
TheraBiogen, Inc. Relocates Corporate Headquarters to New Jersey
Date:12/5/2011

NEW YORK, Dec. 5, 2011 /PRNewswire/ -- TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, today announced the relocation of its corporate headquarters to New Jersey.

The new facility located at 4400 Route 9 South in Manalapan, New Jersey will accommodate the Company's current staff and enable further expansion for the Company's future growth.

Kelly Hickel, CEO of TheraBiogen, commented, "As the demand for our products continues to grow, we have decided to relocate our corporate offices to New Jersey where we will have the capacity to expand with lower operating costs and more flexibility."  He added, "It is an added benefit to be located in New Jersey, the heart of America's pharmaceutical and over the counter drug industry."

Thera Max is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts, Big Y Supermarkets and others.  For more information on Thera Max visit our website at www.theramaxrelief.com, our  Facebook page at facebook.com/theramaxnasalspray or follow us on Twitter at http://twitter.com/TheraMaxRelief.

About TheraBiogen, Inc.TheraBiogen is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit www.theramaxrelief.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.Company Contact: Public Relations Contact: Investor Contact:TheraBiogen, Inc. 

Megan Megale 

Boutcher & BoutcherKelly T. Hickel, CEO 

Megale Public Relations 

Aimee Boutcher732-294-8705 

703-625-8093

973-239-2878kthickel@therabiogen.com 

mmegale@megalepr.com

 


'/>"/>
SOURCE TheraBiogen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Implants Relocates to New Facility in Noblesville, IN
2. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
3. Ferring Pharmaceuticals To Develop Major Corporate Center in Parsippany, New Jersey
4. White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution
5. Accuray Incorporateds CEO to Speak at Lazard Capital Markets 8th Annual Healthcare Conference and Stephens Fall Investment Conference
6. Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
7. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
8. ZONARE Medical Systems Announces Appointment of PJ Ryland as Vice President of Business Development & Corporate Accounts
9. ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
10. nContact, Inc. Launches New Corporate Websites
11. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 2016 Research and ... Thalassaemia Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights - 2016, provides comprehensive ... Thalassaemia market valuations and forecast, Thalassaemia products ...
(Date:5/4/2016)... May 4, 2016 According to ... entitled "Brain Computer Interface Market - Global Industry Analysis, Size, ... brain computer interface (BCI) market  is expected to reach ... is estimated to expand at a CAGR of 14.9 ... A BCI device provides collaboration between the ...
(Date:5/4/2016)... -- According to market research "Global Computed Tomography ... 2022 - Industry Insights by Slice Type (High, Mid and ... P&S Market Research, the global computed tomography market ... expected to grow at a CAGR of 5.0% during 2016-2022. ... expected to witness the faster growth, CAGR of 5.3%, during ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Every year ... most heartfelt wishes of these children. The wishes provide hope and motivation ... and CEO of Make-A-Wish Mississippi, Brent Wilson said, “In 2016, the organization will ...
(Date:5/5/2016)... ... May 05, 2016 , ... Long Island’s fastest growing comprehensive ... noted Long Island eye surgeon, Kathleen Van Valkenburg, MD as part of their ongoing ... Martin, MD, medical director and managing partner of North Shore Eye Care. , ...
(Date:5/5/2016)... ... May 05, 2016 , ... TIME for Kids and The ZAC Foundation ... new partnership to reach nearly 1 million children with important water safety messages before ... the leading cause of accidental death in children one to 6 years of age. ...
(Date:5/5/2016)... ... ... In honor of National Nurses Week 2016, Aya Healthcare , the ... thank a nurse who's made a difference in their life. From Friday, May 6 ... of San Diego/Imperial Counties (up to $10,000) every time someone tells them via social ...
(Date:5/5/2016)... ... , ... The Lung Institute will celebrate its three-year anniversary on May 14 by ... throughout the month of May. To date, the Lung Institute has treated over 2,000 people ... is a testament to the success of this treatment and to the patients who refuse ...
Breaking Medicine News(10 mins):